XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2023
Stockholders' Equity  
Schedule of shareholder's equity

    

    

    

    

Accumulated

    

    

Common

Common

Additional

Other

Total

Stock

Stock Par

Paid-In

Comprehensive

Accumulated

Stockholders’

    

Shares

    

Value

    

Capital

    

 Income

    

Deficit

    

 Equity

(In thousands, except share amounts)

Consolidated balance at December 31, 2022

 

47,200,695

 

$

47

 

$

1,580,829

 

$

1,260

 

$

(1,255,932)

 

$

326,204

Shares issued under stock option and employee stock purchase plans

 

43,986

 

 

 

 

694

 

 

 

 

 

 

694

Stock-based compensation

 

 

 

 

 

4,340

 

 

 

 

 

 

4,340

Unrealized gain on marketable securities

 

 

 

 

 

 

 

863

 

 

 

 

863

Net loss

 

 

 

 

 

 

 

 

 

(29,361)

 

(29,361)

Consolidated balance at March 31, 2023

 

47,244,681

 

$

47

 

$

1,585,863

 

$

2,123

 

$

(1,285,293)

 

$

302,740

Shares issued under stock option and employee stock purchase plans

9,132

133

133

Stock-based compensation

5,217

5,217

Unrealized loss on marketable securities

(51)

(51)

Net loss

(30,502)

(30,502)

Consolidated balance at June 30, 2023

47,253,813

$

47

$

1,591,213

$

2,072

$

(1,315,795)

$

277,537

Shares issued under stock option and employee stock purchase plans

10,384

257

257

Stock-based compensation

7,121

7,121

Unrealized gain on marketable securities

63

63

Net loss

(38,260)

(38,260)

Consolidated balance at September 30, 2023

47,264,197

$

47

$

1,598,591

$

2,135

$

(1,354,055)

$

246,718

    

    

    

    

Accumulated

    

    

Common

Common

Additional

 Other

Total

 Stock

 Stock Par

 Paid-In

 Comprehensive

Accumulated 

Stockholders’

 Shares

 Value

 Capital

 Income

Deficit

 Equity

(In thousands, except share amounts)

Consolidated balance at December 31, 2021

 

46,730,198

$

47

$

1,561,142

$

1,894

$

(1,143,607)

$

419,476

Shares issued under stock option and employee stock purchase plans

 

24,150

 

 

304

 

 

 

304

Stock-based compensation

 

 

 

3,153

 

 

 

3,153

Unrealized loss on marketable securities

 

 

 

 

(1,782)

 

 

(1,782)

Net loss

 

 

 

 

 

(23,050)

 

(23,050)

Consolidated balance at March 31, 2022

 

46,754,348

$

47

$

1,564,599

$

112

$

(1,166,657)

$

398,101

Shares issued under stock option and employee stock purchase plans

 

10,355

 

 

71

 

 

 

71

Stock-based compensation

 

 

 

3,454

 

 

 

3,454

Unrealized loss on marketable securities

 

 

 

 

(529)

 

 

(529)

Net loss

 

 

 

 

 

(36,004)

 

(36,004)

Consolidated balance at June 30, 2022

 

46,764,703

$

47

$

1,568,124

$

(417)

$

(1,202,661)

$

365,093

Shares issued under stock option and employee stock purchase plans

331,360

2,306

2,306

Stock-based compensation

4,496

4,496

Unrealized gain on marketable securities

305

305

Net loss

(26,784)

(26,784)

Consolidated balance at September 30, 2022

47,096,063

$

47

$

1,574,926

$

(112)

$

(1,229,445)

$

345,416